Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2024 Feb 15;43:48. doi: 10.1186/s13046-024-02978-0

Retraction Note: MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ ERK signaling pathways

Ruitao Zhang 1,, Huirong Shi 1, Fang Ren 1, Wei Feng 1, Yuan Cao 1, Gailing Li 1, Zheying Liu 1, Pengcheng Ji 1, Minghui Zhang 1
PMCID: PMC10868034  PMID: 38355629

Retraction Note: J Exp Clin Cancer Res 38, 494 (2019)

10.1186/s13046-019-1494-3

The Editor-in-Chief has retracted this article after concerns were raised about some of the data reported. Specifically:

  • In Fig. 3B, the Con and Met + miR-338-3p images for OVCAR3 cells appear to be duplicates.

  • In Fig. 4A, there appears to be partial overlap between the images of MACC1 and Met conditions and Con and Met + miR-338-3p conditions in OVCAR3 cells.

  • In Fig. 4B, there appears to be partial overlap between the images of miR-338-3p and Met + miR-338-3p conditions of OVCAR3 cells.

The Editor-in-Chief no longer has confidence in the article’s results and conclusions.

Ruitao Zhang agrees with this retraction. The remaining authors did not respond to correspondence from the publisher about this retraction.

Footnotes

The online version of the original article can be found at 10.1186/s13046-019-1494-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES